Short‐term fasting of mice elevates circulating fibroblast growth factor 23 ( FGF23 )
Acta Physiologica · 2023
DOI: 10.1111/apha.14049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Physiologica, 2023. Verfasst von Martina Feger und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, University of Hohenheim, Stuttgart, Germany. Hauptthemen laut MEDLINE: Fibroblast Growth Factor-23, Fibroblast Growth Factors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Aims
Phosphate and vitamin D homeostasis are controlled by fibroblast growth factor 23 (FGF23) from bone suppressing renal phosphate transport and enhancing 24‐hydroxylase ( Cyp24a1 ), thereby inactivating 1,25(OH) 2 D 3 . Serum FGF23 is correlated with outcomes in several diseases. Fasting stimulates the production of ketone bodies. We hypothesized that fasting can induce FGF23 synthesis through the production of ketone bodies.
Methods
UMR106 cells and isolated neonatal rat ventricular myocytes (NRVM) were treated with ketone body β‐hydroxybutyrate. Mice were fasted overnight, fed ad libitum, or treated with β‐hydroxybutyrate. Proteins and further blood parameters were determined by enzyme‐linked immunoassay (ELISA), western blotting, immunohistochemistry, fluorometric or colorimetric methods, and gene expression by quantitative real‐time polymerase chain reaction (qRT‐PCR). Results β‐Hydroxybutyrate stimulated FGF23 production in UMR106 cells in a nuclear factor kappa‐light‐chain enhancer of activated B‐cells (NFκB)‐dependent manner, and in NRVMs. Compared to fed animals, fasted mice exhibited higher β‐hydroxybutyrate and FGF23 serum levels (based on assays either detecting C‐terminal or intact, biologically active FGF23 only), cardiac, pancreatic, and thymic Fgf23 and renal Cyp24a1 expression, and lower 1,25(OH) 2 D 3 serum concentration as well as renal Slc34a1 and αKlotho ( Kl ) expression. In contrast, Fgf23 expression in bone and serum phosphate, calcium, plasma parathyroid hormone (PTH) concentration, and renal Cyp27b1 expression were not significantly affected by fasting.
Conclusion
Short‐term fasting increased FGF23 production, as did administration of β‐hydroxybutyrate, effects possibly of clinical relevance in view of the increasing use of FGF23 as a surrogate parameter in clinical monitoring of diseases. The fasting state of patients might therefore affect FGF23 tests.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, University of Hohenheim, Stuttgart, Germany.
- Department of Pediatric Kidney, Liver and Metabolic Diseases, Pediatric Research Center, Hannover Medical School, Hannover, Germany.
ORCID-Profile: Michael Föller
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Feger, M., Alber, J., Strotmann, J., Grund, A., Leifheit-Nestler, M., Haffner, D., & Föller, M. (2023). Short‐term fasting of mice elevates circulating fibroblast growth factor 23 ( FGF23 ). Acta Physiologica. https://doi.org/10.1111/apha.14049
Vancouver
Feger M, Alber J, Strotmann J, Grund A, Leifheit-Nestler M, Haffner D, et al. Short‐term fasting of mice elevates circulating fibroblast growth factor 23 ( FGF23 ). Acta Physiologica. 2023. doi:10.1111/apha.14049
BibTeX
@article{Feger2023,
author = {Feger, Martina and Alber, Jana and Strotmann, Jörg and Grund, Andrea and Leifheit-Nestler, Maren and Haffner, Dieter and Föller, Michael},
title = {Short‐term fasting of mice elevates circulating fibroblast growth factor 23 ( FGF23 )},
journal = {Acta Physiologica},
year = {2023},
doi = {10.1111/apha.14049}
}
EUVIMED